Subscribe to Email Alerts
Menu
About Us
About INOVIQ
Market Opportunity
Board
Management
Medical & Scientific Advisory Board
Partners
Distributors
Compliance
Careers
Technology
Our Science
NETs Platform
SubB2M Platform
BARD1 Biomarker Technology
hTERT ICC Assay
Intellectual Property
Publications
Resources
Business Development
Products
Our Products
EXO-NET® Pan-Exosome
Product Overview
Technical Information
Data & Figures
Ordering
hTERT ICC Test
Pipeline
Development Pipeline
NeuCA15-3 Test
NeuCA125 Test
EXO-Ovarian Cancer Test
Exosome Therapeutics
Investors
Investor Overview
ASX Announcements
Annual & Financial Reports
Presentations
Share Price Information
AGM
INOVIQ Fact Sheet
Corporate Governance
Shareholder Services
FAQ
Analyst Reports
News & Events
INOVIQ in the News
Conferences & Events
Contact
Contact Us
Subscribe to Email Alerts
ASX Announcements
Heading &
Sub-heading can be edited through HQI
Investors
>
ASX Announcements
Investor Overview
ASX Announcements
Annual & Financial Reports
Presentations
Share Price Information
AGM
INOVIQ Fact Sheet
Corporate Governance
Shareholder Services
FAQ
Analyst Reports
ASX Announcements
Filter by Year:
2025
2024
2023
2022
2021
2020
2019
14-Dec-2022
Resignation of Director
13-Dec-2022
Positive EXO-NET Results in Ovarian Cancer
5-Dec-2022
MST Access Diagnostics Forum Presentation
30-Nov-2022
Change in substantial holding
28-Nov-2022
Results of 2022 Annual General Meeting
28-Nov-2022
CEO AGM Presentation
28-Nov-2022
INOVIQ Settles Legal Proceedings
25-Nov-2022
Commercial and R&D Update
10-Nov-2022
Healthcare Conference Investor Presentation
4-Nov-2022
Appendix 4C - Statement pursuant to Listing Rule 4.7C.3
1
2
3
4
5
6
Next
